Middle East continuous glucose monitoring devices market report size, share, growth drivers, trends, opportunities & forecast 2025–2030

Middle East Continuous Glucose Monitoring Devices Market Overview

• The Middle East Continuous Glucose Monitoring Devices Market is valued at USD 390 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of diabetes, rising healthcare expenditure, and advancements in technology that enhance patient monitoring and management. The demand for continuous glucose monitoring devices is further fueled by the growing awareness of diabetes management among patients and healthcare providers .
• Key players in this market include Saudi Arabia, the United Arab Emirates, and Qatar, which dominate due to their robust healthcare infrastructure, high disposable income, and government initiatives aimed at improving diabetes care. These countries have also seen a rise in the adoption of advanced medical technologies, contributing to the overall growth of the market .
• In 2023, the UAE government implemented the National Diabetes Plan 2023–2030, issued by the Ministry of Health and Prevention. This strategy aims to improve diabetes care and management, including the integration of continuous glucose monitoring devices into standard diabetes treatment protocols. The plan mandates the adoption of digital health tools and advanced monitoring systems to ensure better health outcomes for patients and reduce long-term costs associated with diabetes complications .

Middle East Continuous Glucose Monitoring Devices Market Segmentation

By Product Type:The product type segmentation includes various categories such as Standalone Continuous Glucose Monitoring Systems, Flash Glucose Monitoring Systems, Implantable Continuous Glucose Monitoring Systems, and Sensor Components (Sensors, Transmitters, Receivers). Among these, Standalone Continuous Glucose Monitoring Systems are leading the market due to their ease of use and comprehensive data tracking capabilities. The increasing demand for real-time glucose monitoring and the convenience offered by these systems are driving their popularity among patients and healthcare providers .

By End-User:The end-user segmentation encompasses Hospitals & Clinics, Homecare Settings, Diabetes Centers, and Pharmacies. Hospitals & Clinics dominate this segment due to their capacity to provide comprehensive diabetes management services and access to advanced monitoring technologies. The increasing number of diabetes patients seeking treatment in clinical settings and the growing emphasis on patient-centered care are contributing to the growth of this segment .

Middle East Continuous Glucose Monitoring Devices Market Competitive Landscape

The Middle East Continuous Glucose Monitoring Devices Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Dexcom, Inc., Medtronic plc, Roche Diabetes Care (F. Hoffmann-La Roche Ltd.), Ascensia Diabetes Care, Senseonics Holdings, Inc., Insulet Corporation, Tandem Diabetes Care, Inc., Nova Biomedical, Ypsomed AG, GlySens Incorporated, Glooko, Inc., Med Trust, Diabetes Cloud (Aidex), Sinocare Inc. contribute to innovation, geographic expansion, and service delivery in this space .

Middle East Continuous Glucose Monitoring Devices Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Diabetes:The Middle East faces a significant diabetes challenge, with approximately 108 million adults affected in future, projected to rise to 134 million by 2045, according to the International Diabetes Federation. This alarming trend is driven by urbanization, sedentary lifestyles, and dietary changes. The growing diabetic population necessitates advanced monitoring solutions, propelling the demand for continuous glucose monitoring devices, which are essential for effective diabetes management and prevention of complications.
• Rising Awareness About Continuous Monitoring:Awareness campaigns and educational initiatives have significantly increased the understanding of diabetes management in the Middle East. In future, over 60% of healthcare professionals reported that patients are more informed about continuous glucose monitoring benefits. This heightened awareness is crucial as it encourages patients to adopt these technologies, leading to improved health outcomes and a greater demand for innovative glucose monitoring solutions, thereby driving market growth.
• Technological Advancements in Glucose Monitoring:The continuous glucose monitoring devices market is witnessing rapid technological advancements, with innovations such as real-time data tracking and integration with mobile applications. In future, the introduction of devices featuring Bluetooth connectivity and advanced algorithms has enhanced user experience and accuracy. These innovations are expected to attract more users, as they provide seamless data sharing with healthcare providers, thus fostering better diabetes management and driving market expansion.

Market Challenges

• High Cost of Devices:The high cost of continuous glucose monitoring devices remains a significant barrier to widespread adoption in the Middle East. Prices for advanced devices can exceed USD 1,000, making them unaffordable for many patients, particularly in lower-income regions. This financial burden limits access to essential monitoring technologies, hindering effective diabetes management and contributing to the rising prevalence of diabetes-related complications in the region.
• Limited Reimbursement Policies:In many Middle Eastern countries, reimbursement policies for continuous glucose monitoring devices are inadequate, creating a financial obstacle for patients. For instance, only 30% of health insurance plans cover these devices, leaving a significant portion of the population without financial support. This lack of reimbursement discourages patients from investing in necessary monitoring technologies, ultimately impacting their health outcomes and the overall market growth.

Middle East Continuous Glucose Monitoring Devices Market Future Outlook

The future of the continuous glucose monitoring devices market in the Middle East appears promising, driven by technological advancements and increasing healthcare investments. As governments prioritize diabetes management, initiatives to enhance healthcare infrastructure and accessibility are expected to flourish. Furthermore, the integration of artificial intelligence and telehealth services will likely revolutionize patient monitoring, making it more efficient and personalized. These trends will create a conducive environment for market growth, fostering innovation and improving patient outcomes.

Market Opportunities

• Expansion of Telehealth Services:The rise of telehealth services presents a significant opportunity for continuous glucose monitoring devices. With an estimated 40% increase in telehealth consultations in future, integrating glucose monitoring into these services can enhance patient engagement and adherence to treatment plans, ultimately improving health outcomes and driving device adoption.
• Development of User-Friendly Devices:There is a growing demand for user-friendly continuous glucose monitoring devices, particularly among younger populations. In future, 70% of potential users expressed interest in devices that offer simplified interfaces and mobile app integration. This trend indicates a substantial market opportunity for manufacturers to innovate and cater to consumer preferences, enhancing user experience and expanding market reach.